Correlation Between Merus BV and Viridian Therapeutics

Can any of the company-specific risk be diversified away by investing in both Merus BV and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merus BV and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merus BV and Viridian Therapeutics, you can compare the effects of market volatilities on Merus BV and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merus BV with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merus BV and Viridian Therapeutics.

Diversification Opportunities for Merus BV and Viridian Therapeutics

-0.66

Correlation Coefficient

Merus BV  Viridian Therapeutics

Excellent diversification

The 3 months correlation between Merus and Viridian is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Merus BV and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Merus BV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merus BV are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Merus BV i.e., Merus BV and Viridian Therapeutics go up and down completely randomly.

Pair Corralation between Merus BV and Viridian Therapeutics

Given the investment horizon of 90 days Merus BV is expected to generate 0.83 times more return on investment than Viridian Therapeutics. However, Merus BV is 1.21 times less risky than Viridian Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.13 per unit of risk. If you would invest  4,189  in Merus BV on December 29, 2024 and sell it today you would earn a total of  294.00  from holding Merus BV or generate 7.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Merus BV  vs.  Viridian Therapeutics

Merus BV

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Merus BV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Merus BV may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Viridian Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Merus BV and Viridian Therapeutics

The main advantage of trading using opposite Merus BV and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merus BV position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.

The idea behind Merus BV and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.